Company news
Cynata Therapeutics Limited news in 2022
Cynata Therapeutics Limited's news releases, calls and decks from 2022, newest first.
Cynata Receives $1.65m R&D Tax Incentive Refund
December 4, 2022
Notice of Allowance for Cynata US Patent
November 10, 2022
New Kidney Transplantation Clinical Trial for Cynata & LUMC
November 1, 2022
Notice of Allowance for Australia & Canada Cymerus Patents
October 16, 2022
Successful Completion of Planned DSMB Review of DFU Trial
October 11, 2022
Grant Award to Fund Study of Cynata MSCs in Heart Disease
September 25, 2022
Pipeline Update Following Strategic Portfolio Review
August 11, 2022
Further data supports potency of Cynata MSCs
June 13, 2022
FDA Clears Cynata IND for Phase 2 Trial in GvHD
May 26, 2022
Notice of Allowance for Cynata Chinese Patent
February 27, 2022
Cynata Receives Decision to Grant a Patent in Japan
January 26, 2022
Decks in 2022
- Shareholder Meeting (November 2022)
Shareholder meeting · 20 slides · Nov 22, 2022
- Investor Presentation (March 2022)
Investor deck · 20 slides · Mar 8, 2022